N.B.: This evaluation refers to 2018 and is outdated: display the current evaluation.


United States of America (US)

OpenCorporation rating: 51.32 on 100

Ranking 2018: 122 on 602 companies

Primary and secondary NACE classification:
• Manufacture of pharmaceutical preparations (2120)
• Manufacture of household and sanitary goods and of toilet requisites (1722)

Company description

It is a multi-national manufacturer of pharmaceutical, diagnostic, therapeutic, surgical, biotechnology and personal hygiene products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The company operates in three segments: consumer, pharmaceutical and medical devices and diagnostics.The consumer segment includes a range of products used in the baby and kids care, skin care, oral care, wound care and women's healthcare fields, as well as nutritional and over-the-counter pharmaceutical products. Major brands include Aveeno, Johnson's, Motrin, Neutrogena, ROC, Pepcid Ac and many others. The pharmaceutical segment includes products in the therapeutic areas, such as anti-fungal, anti-infective, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, psychotropic (central nervous system), urology and virology. The medical devices and diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics.It was named #6 on Fortune's 2006 Most Admired Companies list and ranked as the number one company in the annual survey's Pharmaceuticals category. With headquarters in New Brunswick, New Jersey, USA, its objective is to provide scientifically sound, high quality products and services to help heal, cure disease and improve the quality of life.The company was founded in the State of New Jersey in 1887. Through its more than 250 operating companies, it employs approximately 121,000 men and women in 57 countries and sells products throughout the world. The company's international expansion began in 1919 with the establishment of an affiliate company in Canada. The company holds nearly 54,000 U.S. and foreign patents.

[…] show more

OpenCorporation questionnaire

The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.


The rating is calculated on the following metrics (for more information visit the section Methodology).

score (max is 100)

HQ and subsidiaries

loading subsidiaries

* The position of map pins may not reflect the exact location

Latest news about johnson & johnson

20 October 2021 - 09:03

Johnson&Johnson registra un incremento dei profitti, nonostante i ricavi, pari a 23,34 miliardi, siano inferiori alle attese (Cnbc). Secondo il Financial Times+, la società avrebbe speso 1,4 miliardi per creare una società destinata a gestire le conseguenze delle cause legali secondo le quali il talco venduto dalla società sarebbe all'origine di una serie di casi di cancro. J&J Covid vaccine added $502 million to third-quarter sales

Johnson & Johnson reported earnings that beat Wall Street's profit expectations but revenue missed estimates.

23 July 2021 - 06:55

USA, accordo su causa legata a crisi oppioidi: J&J pagherà 5 miliardi

(Teleborsa) – È stato raggiunto un accordo da 26 miliardi di dollari per risolvere le cause legate alla crisi da oppioidi negli Stati Uniti. Secondo quanto riporta Reuters, un gruppo di procu…

27 June 2021 - 08:57

Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York

Johnson & Johnson has agreed to halt sales of opioids nationwide in a $230 million settlement with New York state.

About this evaluation

This evaluation was made on the basis of data publicly available and information provided by company managment.

Claims and support from the company

If as a company manager or official of JOHNSON & JOHNSON you want to enter in touch with our staff, provide more information to OpenCorporation or get an account to access and compile the company questionnaire, please write an email to support@opencorporation.org.

Tell the OpenCorporation team

If you detect corporate behavior in contrast with what emerges from the OpenCorporation corporate rating card in your country, or in the branch where you work, report it to info@opencorporation.org so that our team can take it in account.

More evaluations

Permament links

The link below will always open the 2018 evaluation:

2018: https://www.opencorporation.org/en/ranking/johnson-johnson-inc/2018    url copied

The link below will always open the latest evaluation available:

Last: https://www.opencorporation.org/en/ranking/johnson-johnson-inc/last    url copied